Baraclude 1mg Tablet
By Baraclude
Rx
10 Tablet in a Strip

Composition
Entecavir(1mg)

Manufacturer - BMS India Pvt Ltd
Bristol-Myers Squibb India Pvt. Ltd., The India Bulls Finance Centre, 6th Floor, Tower 1, Senapati Bapat Marg, Elphinstone (W), Mumbai - 400013

Expires on or after
April, 2026

liver
Baraclude 1mg Tablet is considered safe for use in patients with liver disease. It is reassuring to note that no dose adjustment of Baraclude 1mg Tablet is necessary specifically for individuals with liver issues. This information suggests that the medication can be used in patients with liver disease without significant concerns of adverse effects on the liver. It is essential, however, to follow the prescribed dosage and any additional instructions provided by a healthcare professional to ensure the safe and effective use of Baraclude 1mg Tablet.

kidney
Baraclude 1mg Tablet needs caution in patients with kidney disease. Consult your doctor for dosage adjustment as necessary.

alcohol
It is advised to consult your doctor regarding consuming alcohol with Baraclude 1mg Tablet; safety is not known.

driving
"Baraclude 1mg Tablet can reduce alertness, impact vision, and cause drowsiness and dizziness. It is advised not to drive if experiencing these symptoms."

pregnancy
Baraclude 1mg Tablet should not be used during pregnancy. Limited human studies suggest potential risks to the developing baby. Animal studies indicate harmful effects. Your doctor will assess benefits versus risks before prescribing. Discuss with your doctor.

breastfeeding
Baraclude 1mg Tablet may not be safe during breastfeeding as it could pass into breastmilk and harm the baby. It is advisable to consult a doctor before use.
Habit Forming | No |
Chemical Class | Nucleoside analogue |
Therapeutic Class | - |
Action Class | - |
₹1184.33
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024